Pyoderma Vegetans
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase 0/1 Local Application of the Monoclonal Antibody (Mab) sB24M in Patients With Purulent Pyoderma (NCT04895566) | SWISS BIOPHARMA MED GmbH | 2021-05-24 |
Track Pyoderma Vegetans automatically
Every clearance here is in the API, with alerts when new ones post.